About this trial
Coronary computed tomography angiography (CCTA) is a widely accepted initial diagnostic test for individuals suspected of having chronic coronary syndromes. However, there is limited evidence supporting its use in the acute setting. So far, no large-scale randomized trial has examined the performance of CCTA as an alternative to invasive coronary angiography (ICA) in individuals with non-ST-segment elevation myocardial infarction (NSTEACS).
If CCTA were to replace ICA as a routine procedure for individuals with NSTEACS, it could reduce the risk of complications related to ICA, improve patient comfort, expedite decision-making, and reduce healthcare expenses and interhospital transfers.
Eligibility criteria
Qualifiers
Admitted with non-ST-segment elevation myocardial infarction or unstable angina pectoris and an indication for subacute ICA
Elevated troponin or ischemic electrocardiographic changes
Written informed consent
Disqualifiers
Instability requiring acute or emergent ICA
History of percutaneous coronary intervention or coronary artery bypass grafting
Estimated glomerular filtration rate < 30 mL/min/1.73m2
Probable type 2 acute myocardial infarction
Trial design
Treatments tested in this trial
- CCTA
- Conventional ICA
- Team-based interventional triage
Treatment groups
Sponsors and collaborators
Rigshospitalet, Denmark
Lead sponsor
University of Copenhagen
Collaborator